ROCKWELL MEDICAL, INC. Operating Lease, Liability, Current
ROCKWELL MEDICAL, INC. (RMTI) had Operating Lease, Liability, Current of $1.46 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-13
- 2026-06-30: Operating Lease, Liability, Current $1.46M.
- 2026-03-31: Operating Lease, Liability, Current $1.45M.
- 2025-12-31: Operating Lease, Liability, Current $1.16M.
- 2025-09-30: Operating Lease, Liability, Current $1.32M.
| Period end | Operating Lease, Liability, Current | Operating Lease, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.46M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $1.45M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $1.16M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $1.32M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.46M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.46M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $1.57M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $1.55M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.46M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.46M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $1.38M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $1.53M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $1.56M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $1.47M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $1.48M 10-K · filed 2024-03-21 | |
| 2020-12-31 | $1.17M 10-K · filed 2021-03-31 | |
| 2020-09-30 | $1.16M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $1.34M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $1.35M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.49M 10-K · filed 2021-03-31 | $1.49M 10-K · filed 2020-03-17 |
| 2019-09-30 | $1.48M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.64M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $1.68M 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |